Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

European Journal of Nuclear Medicine

Volumn 20, Issue 8, 1993, Pages 716-731

  Krenning, E P ^a   Kwekkeboom, D J ^a   Bakker, W H ^a   Breeman, W A P ^a   Kooij, P P M ^a   Oei, H Y ^a   van Hagen, M ^a   Postema, P T E ^a   de Jong, M ^a   Reubi, J C ^b   Visser, T J ^a   Reijs, A E M ^a   Hofland, L J ^a   Koper, J W ^a   Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apudoma; Lymphoma; Octreotide; Receptor imaging; Somatostatin; Tumour targeting

Indexed keywords

BOMBESIN; IODINE 123; OCTREOTIDE; PENTETATE INDIUM IN 111; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SUBSTANCE P;

CANCER LOCALIZATION; CANCER SCINTISCANNING; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG METABOLISM; GRANULOMA; HUMAN; MONONUCLEAR CELL; NETHERLANDS; PLASMA CLEARANCE; REVIEW;

HUMAN; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; NETHERLANDS; NEUROENDOCRINE TUMORS; OCTREOTIDE; PENTETIC ACID; RECEPTORS, SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T;

EID: 0027517429     PISSN: 03406997     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/BF00181765     Document Type: Article

References (70)

1. Autoradiographic mapping of somatostatin receptors in the rat CNS and pituitary
2. Quantitative electron microscopic autoradiography of insulin, glucagon and somatostatin binding sites on islets
3. Distinct subsets of somatostatin receptors on cultured human lymphocytes
4. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney
5. Somatostatin receptors; an expanding gene family: cloning and functional characterization of human SSTR 3, a protein coupled to adenylyl cyclase
6. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28
7. Molecular cloning and functional expression of a brain-specific somatostatin receptor
8. Molecular biology of somatostatin receptors
9. Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth
10. Somatostatin: a peptide with unexpected physiologic activities
11. The role of somatostatin and its analogs in the diagnosis and treatment of tumours
12. In vitro detection of somatostatin receptors in human tumours
13. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implication
14. Polypeptide hormone production by ‘carcinoid’ apudomas and their relevant cytochemistry
15. High incidence of somatostatin receptors in human meningiomas: biochemical characterization
16. Distribution and biochemical characterization of somatostatin receptors in tumours of the human central nervous system
17. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF-receptors
18. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF receptors
19. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas
20. Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue
21. Localization of endocrine related tumours with radioiodinated analogue of somatostatin
22. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabelling, purification, biological activity and in vivo applications in animals
23. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumours. Consequences with regard to diagnosis, localisation and therapy
24. Somatostatin receptor imaging in the localization of endocrine tumours
25. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer
26. Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualization of Merkel cell tumours and their metastases
27. Somatostatin receptor imaging of endocrine gastrointestinal tumours
28. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism and binding to somatostatin receptor-positive tumours in man
29. Somatostatin receptor scintigraphy with [123In-DTPA-D-PHE1]-octreotide in man: metabolism, dosimetry and comparison with [111I-Tyr-3-]-octreotide
30. [111-In-DTPA-D-PHE1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumours: synthesis, radiolabelling and in vitro validation
31. In vivo application of [111-In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumours in rats
32. Radiation dose to patients from radiopharmaceuticals
33. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes
34. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status
35. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090)
36. Pituitary imaging using a labelled somatostatin analogue in acromegaly
37. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment and studies in vitro
38. Effect of a long-acting somatostatin analogue (SMS 201-995) in patients with pancreatic cholera
39. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue SMS 201-995: symptomatic and peptide responses
40. An odyssey in the land of small tumours
41. Common tumours of the parapharyngeal space: refined imaging diagnosis
42. Familial carotid body tumours: case report and epidemiologic review
43. Somatostatin analogue scintigraphy in carcinoid tumours
44. In-vivo localization of somatostatin receptors with I-123-Tyr-3-octreotide
45. Imaging somatostatin receptor-positive neoplasms with 123I Tyr3-octreotide (TOCT) and 111In [DTPA-D-Phe1]-octreotide (DOCT) somatostatin analogues
46. Indium-111-pentatreotide scintigraphy in detection of primary, recurrent and metastatic gastro-entero-pancreatic (GEP) endocrine tumours
47. Somatostatin receptor imaging with 111In-pentatreotide for whole body studies and high resolution brain SPECT
48. Somatostatin receptor scintigraphy with 111In-pentatreotide in gastroenteropancreatic endocrine tumours (GEP)
49. Rezeptorszintigraphie bei endokrinen gastroenteropankreatischen Tumoren
50. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas
51. Coincidence of EGF receptors and Somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors
52. Endocrine aspects of the diagnosis and treatment of primary brain tumours
53. Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer
54. Identification of human mononuclear leucocytes bearing receptors for somatostatin and glucagon
55. Somatostatin analogue scintigraphy of malignant lymphomas
56. Somatostatin receptors in human renal cell carcinomas
57. In vitro and in vivo identification of somatostatin receptors in medullary thyroid carcinomas, phaeochromocytomas and paragangliomas
58. Thyroid and orbital radiolabelled somatostatin accumulation in Graves' disease and Graves' ophthalmopathy
59. Octreotide and Graves' ophthalmopathy and myxoedema
60. Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebo study in knee involvement
61. Radionuclide therapy revisited
62. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments
63. Octreotide
64. Effects of antibodies against octreotide in two patients with acromegaly
65. Surgical therapy for endocrine tumours of abdominal origin